This invention relates generally to the cellular analysis field, and more specifically to a new and useful system for imaging captured cells.
With an increased interest in cell-specific drug testing, diagnosis, and other assays, systems that allow for individual cell isolation, identification, and retrieval are becoming more desirable within the field of cellular analysis. Furthermore, with the onset of personalized medicine, low-cost, high fidelity cellular sorting systems are becoming highly desirable. However, preexisting cell capture systems and systems to image captured cells suffer from various shortcomings that prevent widespread adoption for cell-specific testing. For example, flow cytometry requires that the cell be simultaneously identified and sorted, and limits cell observation and imaging to a single instance. Flow cytometry thus fails to allow for multiple analyses of the same cell, and does not permit arbitrary cell subpopulation sorting. Conventional microfluidic devices fail to allow for subsequent cell removal without cell damage, which hinders further analysis and imaging of isolated cells. Cellular filters can separate sample components based on size without significant cell damage, but suffer from clogging and do not allow for specific cell identification, isolation, and retrieval. Current systems for capturing cells and imaging/analyzing captured cells are thus severely limited.
Thus, there is a need in the cellular analysis field to create a new and useful system for imaging captured cells or other features of a biological sample at an imaging substrate. This invention provides such a new and useful system.
The following description of the preferred embodiments of the invention is not intended to limit the invention to these preferred embodiments, but rather to enable any person skilled in the art to make and use this invention.
1. System
As shown in
In a specific embodiment, the system 100 is configured to image captured cells within a microfluidic cell capture device that captures and isolates single cells of interest. In the specific embodiment, the system 100 provides unbroken, focused images of all microfluidic cell capture chambers in the microfluidic cell capture device, couples image data with target cell/device identifying information (e.g., location, time) and system parameter information (e.g., illumination information, temperature information), and facilitates light-based cellular diagnostic assays including assays involving fluorescent dyes (e.g., Hoechst dye, Alex Fluor 633, Hex, Rox, Cy5, and Cy5.5). The specific embodiment is further configured to be a benchtop system that operates below a specified decibel level, and is configured to not require room external room darkening to facilitate analyses of captured cells and/or other biological samples. Other variations can involve any other suitable configuration and/or combination of elements that enables imaging of captured cells, and can include elements described in U.S. application Ser. No. 13/557,510, entitled “Cell Capture System and Method of Use”.
1.1 System—Illumination Module
The illumination module 110 comprises a first illumination subsystem 1, and functions to transmit light toward one or more target objects (e.g., captured cells of interest) at the platform 130 to facilitate analyses of the target object(s). Preferably, the illumination module no comprises a first illumination subsystem 111 and a second illumination subsystem 121, such that multiple types of light-based analyses can be enabled by the system 100. The illumination module no can, however, comprise a single illumination subsystem or more than two illumination subsystems to facilitate multiple types of light-based analyses. Additionally, the illumination module no can comprise elements (e.g., housings, filters) configured to reduce or eliminate light not originating from the illumination module no (e.g., light within a room containing the system).
In a first variation, the first illumination subsystem 111 is a bright-field subsystem 111 and the second illumination subsystem is a fluorescence subsystem 121. The bright-field subsystem 111 preferably comprises a wide-spectrum light source as a first light source 112 (e.g., white light source) with an adjustable intensity, and is configured to transmit light through a first set of optics 113 toward a platform 130 configured to position captured cells. In other variations, the first light source 112 may not comprise a wide-spectrum of wavelengths, and/or may not be configured with an adjustable intensity. In one variation, the first light source 112 comprises a white light emitting diode (LED); however, the first light source 112 can additionally or alternatively comprise any other light source configured to provide bright-field images. Light from the first light source 112 thus illuminates a sample at an imaging substrate 350 at the platform 130, and contrast is provided by differential absorbance of light within the sample. The bright-field subsystem 111 preferably provides true bright-field images, but can additionally or alternatively provide composite bright-field images. The first set of optics 113 can comprise a collimator, which functions to collimate light from the first light source 112, and/or a focusing lens, which functions to focus light from the light source onto a captured cell. The focusing lens can be configured to focus light onto a single object (e.g., captured cell), or can one of a set of focusing lenses configured to focus light onto multiple objects (e.g., captured cells, region of a tissue sample) simultaneously. In a first variation, the first light source 112 and the first set of optics 113 are aligned in a vertical direction with respect to a horizontal platform 130, such that light is transmitted in a substantially perpendicular direction toward captured cells of interest at the horizontal platform 130. As such, in the first variation, the first light source 112 can be situated inferior to or superior to the platform 130. In an example of the first variation, light from the bright-field subsystem 111 is configured to impinge upon a biological sample comprising cells of interest, wherein the light is transmitted in a direction toward an optical sensor 150 located above (e.g., superior to) the biological sample, in the orientation shown in
In the first variation, the second illumination subsystem 121 is a fluorescence subsystem 121 comprising a wide-spectrum light source as a second light source 122 with an adjustable intensity, preferably including ultraviolet and/or infrared wavelengths of light, and a second set of optics 123 configured to manipulate light from the second light source 122. The fluorescence subsystem 121 may, however, not be configured to provide an adjustable intensity. In an example, the wide-spectrum second light source 122 comprises an LED that provides light with wavelengths at least in the range between 350-830 nm, such that the filter module 140 can filter light from the second light source 122 to appropriately enable fluorescence light-based analyses using fluorescent dyes (e.g., Hoechst dye, Alexa Fluor 633, FAM, Hex, Rox, Cy5, CY5.5). However, the second light source 122 can additionally or alternatively comprise any other light source(s) configured to facilitate fluorescence light-based analyses. Additionally, the second light source 122 can comprise multiple light sources (e.g., multiple LEDs). In one example comprising multiple light sources, the multiple light sources can produce a certain range of light wavelengths, such that light from the multiple light sources can be filtered to reduced wavelength ranges for imaging and analysis of target objects according to specific assay protocols. The second set of optics 123 can comprise a collimator, which functions to collimate light from the second light source 122, and/or a focusing lens, which functions to focus light from the light source onto a captured cell. The focusing lens can be configured to focus light onto a single target object (e.g., captured cell), or can be one of a set of focusing lenses configured to focus light onto multiple target objects (e.g., captured cells, region of a tissue sample) simultaneously. In a first variation, the second light source 122 and the second set of optics 123 are aligned in a horizontal direction with respect to a horizontal platform 130, such that light is transmitted in a substantially parallel direction prior to being reflected (e.g., using a mirror 102) toward captured cells of interest or tissue at the horizontal platform 130. In an example of the first variation, light from the second illumination subsystem 121 is configured to impinge upon a biological sample comprising cells of interest, wherein the light from the second illumination subsystem 121 is transmitted in a direction away from an optical sensor 150 located above the biological sample, after being reflected by a mirror 102 and a dichroic mirror 143, in the orientation shown in
In alternative variations, at least one of the first illumination subsystem 111 and the second illumination subsystem 121 can comprise a dark-field subsystem, a confocal subsystem, a phase-contrast subsystem, and/or any other suitable imaging subsystem. Additionally, in other variations, at least one of the first illumination subsystem 111 and the second illumination subsystem 121 can be coupled to an actuation subsystem 128 configured to translate, rotate, or angularly displace a illumination subsystem 111, 121 relative to a biological sample comprising cells of interest.
1.2 System—Platform
As shown in
As shown in
As shown in
In automated variations of the system 100, the platform control module 133 can comprise an actuator configured to automatically control motion of the platform 130. The actuator is preferably configured to affect motion of the platform 130 in at least two directions (e.g., X and Y directions); however, the actuator can be configured to affect motion of the platform 130 in less than two directions, more than two directions (e.g., X, Y, and Z directions), and/or in rotation. In an example of an automated variation, as shown in
The guide 138 functions to receive and align an imaging substrate 350 that contains a biological sample and/or target objects (e.g., captured cells of interest), such that the biological sample and/or target objects can be properly imaged and analyzed. The guide 138 can be a suitably-sized recess at one surface of the platform 130, and/or can comprise a ridge, rail, or tab configured to align the imaging substrate 350 in relation to the platform 130. Furthermore, the guide 138 can preferably only receive the imaging substrate 350 in one orientation, such that positive orientation confirmation is enabled by the guide 138; however, the guide 138 can alternatively be configured to receive an imaging substrate 350 in multiple orientations. The guide 138 preferably has at least one aperture in order to enable light transmission through the imaging substrate 350, thereby facilitating imaging of a target object at the imaging substrate 350. The guide 138 can additionally be one of a set of guides of the platform 130, such that the platform is configured to receive and align multiple imaging substrates 350. In one variation, the platform 130 can include an array of guides arranged in multiple rows, as shown in
As shown in
As shown in
In other variations, the platform 130 additionally include or be coupled to a fluidic manifold 127 coupled to a fluid source, as shown in
In a first specific example, as shown in
In a second specific example, as shown in
1.3 System—Filter Module
The filter module 140 comprises an excitation filter 141 configured to receive light from a fluorescence subsystem 121 and transmit light at excitation wavelengths, a dichroic mirror 142 configured to receive and reflect light from the excitation filter 141 toward target objects at the platform 130, and an emission filter 143 configured to receive and transmit light from the target objects toward an optical sensor 150. The filter module 140 thus functions to transmit light at excitation wavelengths toward target objects (e.g., captured cells of interest) and to receive light at emission wavelengths from the target objects, in order to facilitate imaging and analysis of the target objects. The filter module 140 is preferably one of a set of filter modules of the system 100; however, the system 100 can alternatively include only a single filter module. The filter module(s) 140 can comprise a set of excitation filters 144, a set of emission filters 145, and a set of dichroic mirrors 146, such that multiple ranges of excitation light can be transmitted, and multiple ranges of emitted light can be transmitted to the optical sensor 150. In variations comprising a set of excitation filters 141, the set of excitation filters 141 can include band pass filters configured to transmit light between two bounding wavelengths, short pass filters configured to transmit light below a certain wavelength, and long pass filters configured to transmit light above a certain wavelength. Additionally, the set of excitation filters 141 can comprise interchangeable filters, such that individual excitation filters can be interchanged to provide different excitation wavelengths of light, and multiple excitation filters can be stacked to provide composite analyses; however, the set of excitation filters 141 can alternatively be fixed, such that the filter module 140 is only configured to transmit a fixed range of excitation wavelengths.
In a first variation comprising a set of excitation filters 144, excitation filters 141 in the set of excitation filters 144 are chosen to transmit different desired ranges of excitation wavelengths. In a first example of the first variation, the set of excitation filters 144 can comprise a filter that transmits light at wavelengths from 350-390 nm (for Hoescht dye-based assays), a filter that transmits light at wavelengths from 420-480 nm (for other Hoescht dye-based assays), a filter that transmits light at a nominal wavelength of 632 nm (for Alexa Fluor 633-based assays), and a filter that transmits light at a nominal wavelength of 647 nm (for other Alexa Fluor 633-based assays). In a second example of the first variation, the set of excitation filters 144 can comprise a filter that transmits light at wavelengths from 450-490 nm (for FAM-based assays), a filter that transmits light at wavelengths from 510-540 nm (for Hex-based assays), a filter that transmits light at wavelengths from 555-600 nm (for Rox-based assays), a filter that transmits light at wavelengths from 615-635 nm (for Cy5-based assays), and a filter that transmits light at wavelengths fro 665-685 nm (for Cy5.5-based assays).
The dichroic mirror 142 of the filter module 140 is configured to align with an excitation filter 141, and functions to receive and reflect light from the excitation filter 141 toward a target object at the platform 130. The dichroic mirror 142 also functions to receive and transmit light from an emission filter 143 toward an optical sensor 150, which is described in more detail below. In variations comprising a set of dichroic mirrors 145, each dichroic mirror 142 in the set of dichroic mirrors 145 is preferably identical in orientation relative to an excitation filter 141 or a set of excitation filters 144, and an emission filter 143 of a set of emission filters 146. The dichroic mirror 142 or the set of dichroic mirrors 145 can also be configured to reflect and transmit appropriate wavelengths of light based on the application.
The emission filter 143 is configured to align with a dichroic mirror 142, and functions to transmit emission wavelengths of light from the target object at the platform 130, and to filter out excitation wavelengths of light. The filter module 140 can further comprise a set of emission filters 146, such that multiple different ranges of light wavelengths can be detected from the target objects at the platform 130. In variations comprising a set of emission filters 146, the set of emission filters 143 can include band pass filters, configured to transmit light between two bounding wavelengths, short pass filters configured to transmit light below a certain wavelength, and long pass filters configured to transmit light above a certain wavelength. Preferably, the set of emission filters 146 is interchangeable and/or stackable, such that individual emission filters can be interchanged or stacked to transmit and/or block different wavelengths of light; however, the set of emission filters 146 can alternatively be fixed, such that the filter module 140 is only configured to transmit a fixed range of emission wavelengths.
In a first variation comprising a set of emission filters 146, emission filters 143 in the set of emission filters 146 are chosen to transmit different desired ranges of emission wavelengths. In an example of the first variation, the set of emission filters 146 can comprise a filter that transmits light at wavelengths from 507-540 nm (for FAM-based assays), a filter that transmits light at wavelengths from 557-580 nm (for Hex-based assays), a filter that transmits light at wavelengths from 618-638 nm (for Rox-based assays), a filter that transmits light at wavelengths from 655-680 nm (for Cy5-based assays), and a filter that transmits light at wavelengths from 700-830 nm (for Cy5.5-based assays).
The filter module 140 can be fixed within the system 100, but can alternatively be coupled to an actuator configured to displace and/or align the filter module 140 relative to other system elements. As such, the filter module 140 can be coupled to a filter stage 149 coupled to the actuator and configured to translate and/or rotate the filter module 140 into position with respect to one or more light sources 112, 122 of illumination subsystems ni, 121 of the illumination module no. Furthermore, the filter module 140 can be one of a set of filter modules coupled to a filter stage 149, such that each filter module 140 in the set of filter modules 140 can be translated or rotated into position with respect to one or more light sources 112, 122 of illumination subsystems in, 121 of the illumination module no. As such, the filter stage 149 preferably includes at least one aperture configured to allow light to be transmitted through the filter module(s) 140 to a target object at the platform 130; however, the filter stage 149 can additionally or alternatively be substantially transparent to allow light transmission, or can allow light transmission in any other suitable manner. Additionally, the filter stage 149 can be defined by a circular footprint, a rectangular footprint, or any other suitable footprint (e.g., polygonal, non-polygonal). The filter stage 149 is preferably situated superior to the platform 130 and inferior to an optical sensor 150; however, the filter stage 149 can alternatively be situated relative to other elements of the system 100 in any other suitable manner.
In one variation, the filter stage 149 can be coupled to an actuator that translates the filter stage 149 and the filter module(s) 140 along one or more axes (e.g., X, Y, and/or Z axes) into a desired position in a consistent manner (e.g., using a linear encoder, using a sensor able to provide position detection, etc.). In an another variation, the filter stage 149 can be coupled to an actuator that rotates the filter stage 149 and the filter module(s) 140 into a desired position in a consistent manner (e.g., using a rotary encoder, using a stepper motor, etc.), about an axis perpendicular to a planar surface of the filter stage 149. In this variation, the filter stage 149 is preferably rotatable by at least 180° in clockwise and counterclockwise directions; however, in variations of this variation, the filter stage 149 can be rotatable through any other suitable angular displacement (e.g., 360° in one or two directions, less than 360° in one direction, etc.). The axis of rotation of the filter stage 149 is preferably offset and parallel to the axis of rotation of the platform 130 in variations of the system 100 including a rotating platform 130; however, the axis of rotation of the filter stage 149 can alternatively be non-offset and/or non-parallel to the axis of rotation of the platform 130 in variations of the system 100 including a rotating platform 130. In still another variation, the filter stage 149 can be coupled to one or more actuators that translate the filter stage 149 and the filter module(s) 140 along one or more axes (e.g., X, Y, and/or Z axes) and rotate the filter stage 149 and the filter module(s) 140 into a desired configuration. In an example, as shown in
In another specific example of the filter module 140, in the orientation shown in
1.4 System—Optical Sensor and Focusing and Optics Module
The optical sensor 150 is configured to align with an emission filter 143 of the filter module 140, and functions to receive light from the emission filter 143 to facilitate imaging and analysis of a target object (e.g., captured cell of interest). Preferably, the optical sensor 150 is oriented perpendicular to the platform 130, as shown in
The focusing and optics module 160 preferably comprises a lens 161 configured to focus light from the illumination module onto a target object at the platform 130, and/or a lens 162 configured to focus light from the target object at the platform 130 onto the optical sensor 150. The lens can be any suitable lens (objective lens) with any suitable magnification (e.g., 10×-40×) and numeric aperture (e.g., ¼″). The lens 161, 162 can also be one of a set of lenses configured to focus light onto individual target objects (e.g., individual lenses focus light onto individual captured cells of interest), or can be a single lens 161 configured to focus light onto multiple target objects (e.g., captured cells of interest within a microfluidic cell capture device, a tissue region, etc.) at the platform 130. The lens(es) 161, 162 can be aligned with the excitation filter 141, the dichroic mirror 142, and/or the emission filter 143 of the filter module 140, such that light transmitted from or reflected off of the excitation filter 141, the dichroic mirror 142, and/or the emission filter 143 is appropriately focused. The lens(s) can however, be aligned in any suitable configuration relative to other elements of the system 100 and configured to focus incident light by way of any suitable number of optics elements (e.g., dichroic mirrors, mirrors, etc.).
The lens(es) 161 of the focusing and optics module 160 can be further configured to translate in one or more directions and/or rotate about any suitable number of axes, to facilitate focusing or auto-focusing of light onto the platform 130 and/or onto the optical sensor 150. In variations wherein the lens(es) 161 of the focusing and optics module 160 are configured to translate, translation can be facilitated using an optics manipulation module 167, including an actuator 166 and/or a lens selector 165, to enable automated or semi-automated functionalities (e.g., autofocusing, automagnification, etc.). The actuator 166 preferably couples to the lens(es) 161, 162 and/or the lens selector 165, and provides translation along at least one axis (e.g., X-axis, Y-Axis, Z-axis); however, the actuator 166 can be configured to couple to any other suitable element of the system 100 in order to enable translation of elements of the focusing and optics module 160, and/or can provide translation along multiple axes (e.g., X and Z-axes, Y and Z-axes, X and Y-axes). The lens selector 165 preferably rotates one of a set of lenses into alignment (e.g., as in a revolving nosepiece); however, variations of the lens selector 165 can additionally or alternatively translate a lens of a set of lenses into alignment.
In a specific example, as shown in
Furthermore, while variations and examples of translation and/or rotation in the platform 130, the filter module 140, and the focusing and optics module 160 have been described above, other embodiments of the system 100 can include translation, rotation, and/or relative motion through any suitable path, of any suitable element of the system 100, in order to facilitate light transmission and alignment of optics elements in any other suitable manner.
1.6 System—Other Elements
As shown in
As shown in
As shown in
In one variation, the thermal control module 190 comprises a single element configured to contact a surface of an imaging substrate 350. In another variation, the thermal control module includes multiple elements, wherein each element is configured to heat or cool a given portion of an imaging substrate 350. In one example, the thermal control module 190 can be used to control the temperature of a microfluidic cell capture device being imaged and/or analyzed by the system 100, by heating and/or cooling the microfluidic cell capture device according to a specific protocol during imaging. In an example, of the variation, the thermal control module 190 can heat the microfluidic cell capture device to incubate the cells of interest captured therein, and can cool microfluidic cell capture device to quench a reaction or incubation process.
The system 100 can further comprise an image stabilization module 200 configured to reduce or eliminate artifacts within image data due to unwanted system 100 motion. In one variation, as shown in
As shown in
In a variation wherein the control system 170 is coupled to the illumination module no, the control system 170 can function to adjust light intensity provided by the illumination module no. For example, the control system 170 can control bright field illumination intensity and fluorescence illumination intensity using potentiostats or other suitable elements. In a variation wherein the control system 170 is coupled to the platform 130, the control system 170 can function to manipulate translation, angular displacement, and/or rotation of the platform 130 about any suitable number of axes. In a variation wherein the control system 170 is coupled to the filter module 140, the control system 170 can facilitate adjustments to filter configurations (e.g., interchanging and/or stacking of filters) to enable various light-based biological sample assays to be performed. In a variation wherein the control system 170 is coupled to the optical sensor 150, the control system 170 can adjust image capture parameters (e.g., resolution, capture, exposure, etc.). In a variation wherein the control system 170 is coupled to the focusing and optics module 160, the control system 170 can facilitate motion of the platform 130 and/or the focusing and optics module 160, in order to enable autofocusing functions of the system 100. For example, the system 100 can autofocus to depth fiducials of a cell capture device, or can autofocus on individual cells captured within a cell capture device. In a variation wherein the control system 170 is coupled to the tag identifying system 180, the control system 170 can function to automate reading of tags 181, and can further function to facilitate transfer of information from the tags 181 to a processor 220. In a variation wherein the control system 170 is coupled to a thermal control module 190, the control system 170 can facilitate heating of an imaging substrate 350 to a specified thermal state (e.g., temperature), maintaining the imaging substrate 350 at the specified thermal state, and/or cooling the imaging substrate 350. Other variations of the control system 170 can function automate handling, transfer, and/or storage of other elements of the system 100, Alternative combinations of the above variations can involve a single control element, or multiple control elements configured to perform all or a subset of the functions described above.
As shown in
In variations comprising a user interface 211 with a display, the user interface 211 functions to display processed and/or unprocessed data produced by the system 100, settings of the system 100, information obtained from tag identifying system 180, or any other suitable information. Alternatively, the processor 220 may not be coupled to a user interface 211, and/or can comprise a linking interface 230 configured to facilitate transfer of processed and/or unprocessed data produced by the system 100, settings of the system 100, information obtained from a tag identifying system 180, or any other appropriate information to a device external to the system 100.
The linking interface 230 is preferably a wired connection, wherein the linking interface 230 is configured to couple to a wired connector. The linking interface 230 can facilitate one-way and or two-way communication between system elements and the processor, and can communicate with the processor via inter-integrated circuit communication (I2C), one-wire, master-slave, or any other suitable communication protocol. However, the linking interface 230 can transmit data in any other way and can include any other type of wired connection (such as a USB wired connection) that supports data transfer between system elements and the processor 220. Alternatively, the linking interface 230 can be a wireless interface. In a wireless variation of the linking interface 230, the linking interface 230 can include a Bluetooth module that interfaces with a second Bluetooth module coupled to another element over Bluetooth communications. The linking interface 230 of the wireless variation can alternatively implement other types of wireless communications, such as Wi-Fi, 3G, 4G, radio, or other forms of wireless communication.
Other elements of the system 100 can include a storage module 240, which functions to provide local system storage of data. Variations of the system 100 including a storage module thus allow data to be stored locally prior to transferring the data to an element external to the system. In a specific example, the storage module can provide local storage adequate to accommodate storage of up to 10 runs of the system 100 per day, for a month period of time.
1.7 System—Specific Examples
In a first specific example, as shown in
In the first specific example, the platform 130 comprises nine guides 138 arranged in a uniformly distributed circular array, each guide 138 proximal to a retainer 139 that holds an imaging substrate 350 at the platform 130. The platform 130 in the first specific example is further coupled to a platform control module 133 comprising a translation stage 334 configured to translate the platform 130 in coordinate directions parallel to the platform 130 (e.g., X, Y directions), by way of a translation controller 335 that automates translation of the translation stage 334. The platform control module 133 in the second specific example further includes an actuator configured to angularly displace the platform 130 about an axis perpendicular to the platform, thereby rotating one of multiple imaging substrates 350 with target objects into desired positions for observation and analysis. In variations of the first specific example, the platform control module 133 can additionally or alternatively be configured to rotate the platform 130 about an axis parallel the platform to generate a distribution of focal lengths across the platform 130 for calibration of the relative locations of the optical sensor 150 and the target object(s) at the platform 130, thereby facilitating achievement of a desired focal length to analyze the target object(s). Variations of the first specific example can, however, be configured in any other suitable manner.
In a second specific example, as shown in
The platform 130 in the second specific example is further coupled to a platform control module 133 comprising a translation stage 334 configured to translate the platform 130 in coordinate directions parallel to the platform 130 (e.g., X and Y directions), by way of a translation controller 335 that automates translation of the translation stage 334. The translation stage 334 and translation controller 335 of the platform control module 133 can translate the platform in an X direction by a span of 9″ and in a Y direction by a span of 5″ in the second specific example. The platform control module 133 in the second specific example further includes an actuator configured to angularly displace the platform 130 about an axis parallel the platform to generate a distribution of focal lengths across the platform 130 for calibration of the relative locations of the optical sensor 150 and the target object(s) at the platform 130, thereby facilitating achievement of a desired focal length to analyze the target object(s). Variations of the second specific example can, however, be configured in any other suitable manner.
The system 100 of the preferred embodiment and variations thereof can be embodied and/or implemented at least in part as a machine configured to receive a computer-readable medium storing computer-readable instructions. The instructions are preferably executed by computer-executable components preferably integrated with the system 100 and one or more portions of the processor 220. The computer-readable medium can be stored on any suitable computer-readable media such as RAMs, ROMs, flash memory, EEPROMs, optical devices (CD or DVD), hard drives, floppy drives, or any suitable device. The computer-executable component is preferably a general or application specific processor, but any suitable dedicated hardware or hardware/firmware combination device can alternatively or additionally execute the instructions.
As a person skilled in the art will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the preferred embodiments of the invention without departing from the scope of this invention defined in the following claims.
This application is a is a continuation of U.S. patent application Ser. No. 15/931,928, filed 14 May 2020, which is a continuation of U.S. patent application Ser. No. 16/589,778, filed 1 Oct. 2019, which is a continuation of U.S. patent application Ser. No. 15/430,833, filed 13 Feb. 2017, which is a continuation of U.S. patent application Ser. No. 15/199,245, filed 30 Jun. 2016, now issued as U.S. Pat. No. 9,612,199, which is a continuation of U.S. patent application Ser. No. 14/208,458, filed 13 Mar. 2014, now issued as U.S. Pat. No. 9,404,864, which claims the benefit of U.S. Provisional Application Ser. No. 61/902,431, filed on 11 Nov. 2013, and U.S. Provisional Application Ser. No. 61/779,090, filed on 13 Mar. 2013, which are all incorporated herein in their entirety by this reference.
Number | Name | Date | Kind |
---|---|---|---|
4475411 | Wellerfors | Oct 1984 | A |
4551435 | Liberti et al. | Nov 1985 | A |
4710635 | Chupp | Dec 1987 | A |
5266269 | Niiyama et al. | Nov 1993 | A |
5281540 | Merkh et al. | Jan 1994 | A |
5491343 | Brooker | Feb 1996 | A |
5541064 | Bacus et al. | Jul 1996 | A |
5547849 | Baer et al. | Aug 1996 | A |
5851488 | Saul et al. | Dec 1998 | A |
5883370 | Walker et al. | Mar 1999 | A |
5888370 | Becker et al. | Mar 1999 | A |
5993630 | Becker et al. | Nov 1999 | A |
5993632 | Becker et al. | Nov 1999 | A |
6016712 | Warden et al. | Jan 2000 | A |
6127177 | Toner et al. | Oct 2000 | A |
6133030 | Bhatia et al. | Oct 2000 | A |
6150180 | Parce et al. | Nov 2000 | A |
6174683 | Hahn | Jan 2001 | B1 |
6221663 | Bhatia et al. | Apr 2001 | B1 |
6228624 | Terstappen | May 2001 | B1 |
6281008 | Komai et al. | Aug 2001 | B1 |
6287832 | Becker et al. | Sep 2001 | B1 |
6365362 | Terstappen et al. | Apr 2002 | B1 |
6410724 | Dejean et al. | Jun 2002 | B1 |
6433134 | Patron et al. | Aug 2002 | B1 |
6525997 | Narayanaswami et al. | Feb 2003 | B1 |
6563634 | Shimada et al. | May 2003 | B2 |
6613525 | Nelson et al. | Sep 2003 | B2 |
6623983 | Terstappen et al. | Sep 2003 | B1 |
6641708 | Becker et al. | Nov 2003 | B1 |
6645731 | Terstappen et al. | Nov 2003 | B2 |
6692952 | Braff et al. | Feb 2004 | B1 |
6790330 | Gascoyne et al. | Sep 2004 | B2 |
6821484 | Gregersen | Nov 2004 | B1 |
6861259 | Columbus | Mar 2005 | B2 |
6866823 | Wardlaw | Mar 2005 | B2 |
6960449 | Wang et al. | Nov 2005 | B2 |
7008789 | Gambini et al. | Mar 2006 | B2 |
7035170 | Narayanaswami et al. | Apr 2006 | B2 |
7046357 | Weinberger et al. | May 2006 | B2 |
7148492 | Loney et al. | Dec 2006 | B2 |
7172866 | Hahn et al. | Feb 2007 | B2 |
7198901 | Rachlin | Apr 2007 | B1 |
7217520 | Tsinberg et al. | May 2007 | B2 |
7238521 | Hahn et al. | Jul 2007 | B2 |
7248352 | Hamamatsu et al. | Jul 2007 | B2 |
7258990 | Falcovitz-Gerassi et al. | Aug 2007 | B2 |
7266777 | Scott et al. | Sep 2007 | B2 |
7294468 | Bell et al. | Nov 2007 | B2 |
7316897 | Bisconte et al. | Jan 2008 | B2 |
7332288 | Terstappen et al. | Feb 2008 | B2 |
7338760 | Gong et al. | Mar 2008 | B2 |
7354389 | Kureshy et al. | Apr 2008 | B2 |
7439062 | Bhatt et al. | Oct 2008 | B2 |
7449558 | Yao et al. | Nov 2008 | B2 |
7449778 | Sander | Nov 2008 | B2 |
7507528 | Albert et al. | Mar 2009 | B2 |
7588672 | Unger et al. | Sep 2009 | B2 |
7595157 | Tsinberg | Sep 2009 | B2 |
7597528 | Rodi | Oct 2009 | B2 |
7604777 | Columbus | Oct 2009 | B2 |
7638464 | Fagnani et al. | Dec 2009 | B2 |
7695956 | Tsinberg et al. | Apr 2010 | B2 |
7704322 | Hansen et al. | Apr 2010 | B2 |
7710563 | Betzig et al. | May 2010 | B2 |
7738320 | Taha | Jun 2010 | B2 |
7763704 | Ding et al. | Jul 2010 | B2 |
7815863 | Kagan et al. | Oct 2010 | B2 |
7858757 | Hollmann et al. | Dec 2010 | B2 |
7863012 | Rao et al. | Jan 2011 | B2 |
7901950 | Connelly et al. | Mar 2011 | B2 |
7964349 | Bell et al. | Jun 2011 | B2 |
8008032 | Forsyth et al. | Aug 2011 | B2 |
8013298 | Khursheed | Sep 2011 | B2 |
8021614 | Huang et al. | Sep 2011 | B2 |
8103080 | George et al. | Jan 2012 | B2 |
8105769 | Bell et al. | Jan 2012 | B2 |
8105780 | Su et al. | Jan 2012 | B2 |
8131053 | Ortyn et al. | Mar 2012 | B2 |
8158410 | Tang et al. | Apr 2012 | B2 |
8174698 | Peter et al. | May 2012 | B2 |
8175371 | George et al. | May 2012 | B2 |
8186913 | Toner et al. | May 2012 | B2 |
8211301 | Safar et al. | Jul 2012 | B2 |
8232112 | Willson et al. | Jul 2012 | B2 |
8252517 | Thomas et al. | Aug 2012 | B2 |
8293524 | Ionescu-Zanetti et al. | Oct 2012 | B2 |
8304230 | Toner et al. | Nov 2012 | B2 |
8329422 | Rao et al. | Dec 2012 | B2 |
8372579 | Toner et al. | Feb 2013 | B2 |
8372584 | Shoemaker et al. | Feb 2013 | B2 |
8406498 | Ortyn et al. | Mar 2013 | B2 |
8465916 | Bell et al. | Jun 2013 | B2 |
8628923 | Hamilton et al. | Jan 2014 | B2 |
8658418 | Daridon | Feb 2014 | B2 |
8680025 | Cooney | Mar 2014 | B2 |
8730479 | Ness et al. | May 2014 | B2 |
8765454 | Zhou et al. | Jul 2014 | B2 |
8771609 | Ehben et al. | Jul 2014 | B2 |
8802367 | Taniguchi et al. | Aug 2014 | B2 |
8936945 | Handique et al. | Jan 2015 | B2 |
8986988 | Karnik et al. | Mar 2015 | B2 |
9103754 | Handique et al. | Aug 2015 | B2 |
9110026 | Collins | Aug 2015 | B2 |
9133499 | Di Carlo et al. | Sep 2015 | B2 |
9145540 | Deutsch et al. | Sep 2015 | B1 |
9174216 | Handique et al. | Nov 2015 | B2 |
9188586 | Fan et al. | Nov 2015 | B2 |
9194001 | Brenner | Nov 2015 | B2 |
9200245 | Deutsch et al. | Dec 2015 | B2 |
9201060 | Voldman et al. | Dec 2015 | B2 |
9249459 | Hamilton et al. | Feb 2016 | B2 |
9260753 | Xie et al. | Feb 2016 | B2 |
9290808 | Fodor et al. | Mar 2016 | B2 |
9290809 | Fodor et al. | Mar 2016 | B2 |
9304065 | Fowler et al. | Apr 2016 | B2 |
9315768 | Vrouwe et al. | Apr 2016 | B2 |
9315857 | Fu et al. | Apr 2016 | B2 |
9329170 | Clarke et al. | May 2016 | B2 |
9364829 | Heid et al. | Jun 2016 | B2 |
9410201 | Hindson et al. | Aug 2016 | B2 |
9429500 | Fowler et al. | Aug 2016 | B2 |
9506845 | Fowler et al. | Nov 2016 | B2 |
9507609 | Glazer et al. | Nov 2016 | B2 |
9513195 | Handique et al. | Dec 2016 | B2 |
9567645 | Fan et al. | Feb 2017 | B2 |
9567646 | Fan et al. | Feb 2017 | B2 |
9598736 | Fan et al. | Mar 2017 | B2 |
9610581 | Handique et al. | Apr 2017 | B2 |
9637799 | Fan et al. | May 2017 | B2 |
9701998 | Hindson et al. | Jul 2017 | B2 |
9707562 | Handique et al. | Jul 2017 | B2 |
9708659 | Fodor et al. | Jul 2017 | B2 |
9746413 | Handique et al. | Aug 2017 | B2 |
9752181 | Handique et al. | Sep 2017 | B2 |
9757707 | Husain et al. | Sep 2017 | B2 |
9802193 | Handique et al. | Oct 2017 | B2 |
9840732 | Anderson et al. | Dec 2017 | B2 |
9845502 | Fodor et al. | Dec 2017 | B2 |
9850483 | Clarke et al. | Dec 2017 | B2 |
9952126 | Fowler et al. | Apr 2018 | B2 |
9995662 | Husain et al. | Jun 2018 | B2 |
10376889 | Masquelier et al. | Aug 2019 | B1 |
10391492 | Handique et al. | Aug 2019 | B2 |
10391493 | Handique et al. | Aug 2019 | B2 |
10401373 | Holmes et al. | Sep 2019 | B1 |
10408736 | Handique | Sep 2019 | B1 |
10533152 | Belgrader et al. | Jan 2020 | B1 |
10718007 | Handique et al. | Jul 2020 | B2 |
20020009759 | Terstappen et al. | Jan 2002 | A1 |
20020028431 | Julien | Mar 2002 | A1 |
20020036142 | Gascoyne et al. | Mar 2002 | A1 |
20020036823 | Shimada et al. | Mar 2002 | A1 |
20020098535 | Wang et al. | Jul 2002 | A1 |
20020109838 | Columbus | Aug 2002 | A1 |
20020119482 | Nelson et al. | Aug 2002 | A1 |
20020192808 | Gambini et al. | Dec 2002 | A1 |
20030103662 | Finkbeiner | Jun 2003 | A1 |
20030129676 | Terstappen et al. | Jul 2003 | A1 |
20030138941 | Gong et al. | Jul 2003 | A1 |
20040029241 | Hahn et al. | Feb 2004 | A1 |
20040106130 | Besemer et al. | Jun 2004 | A1 |
20040160599 | Hamamatsu et al. | Aug 2004 | A1 |
20040191891 | Tsinberg et al. | Sep 2004 | A1 |
20040218472 | Narayanaswami et al. | Nov 2004 | A1 |
20040229349 | Daridon | Nov 2004 | A1 |
20040239922 | Modlin | Dec 2004 | A1 |
20040248318 | Weinberger et al. | Dec 2004 | A1 |
20050001176 | Loney et al. | Jan 2005 | A1 |
20050014201 | Deuthsch | Jan 2005 | A1 |
20050037343 | Fagnani et al. | Feb 2005 | A1 |
20050042685 | Albert et al. | Feb 2005 | A1 |
20050063863 | Columbus | Mar 2005 | A1 |
20050105172 | Hasegawa | May 2005 | A1 |
20050112589 | Hahn et al. | May 2005 | A1 |
20050118640 | Kureshy et al. | Jun 2005 | A1 |
20050123445 | Blecka et al. | Jun 2005 | A1 |
20050158804 | Yao et al. | Jul 2005 | A1 |
20050164236 | Su et al. | Jul 2005 | A1 |
20050181463 | Rao et al. | Aug 2005 | A1 |
20050265815 | Rodi | Dec 2005 | A1 |
20060040274 | Tsinberg | Feb 2006 | A1 |
20060040407 | Falcovitz-Gerassi et al. | Feb 2006 | A1 |
20060050142 | Scott et al. | Mar 2006 | A1 |
20060115380 | Kagan et al. | Jun 2006 | A1 |
20060128006 | Gerhardt et al. | Jun 2006 | A1 |
20060141045 | Bhatt et al. | Jun 2006 | A1 |
20060147959 | Bell et al. | Jul 2006 | A1 |
20060160243 | Tang et al. | Jul 2006 | A1 |
20060257992 | McDevitt et al. | Nov 2006 | A1 |
20060263250 | Blouin et al. | Nov 2006 | A1 |
20070026381 | Huang et al. | Feb 2007 | A1 |
20070111302 | Handique et al. | May 2007 | A1 |
20070154960 | Connelly et al. | Jul 2007 | A1 |
20070161051 | Tsinberg et al. | Jul 2007 | A1 |
20070172903 | Toner et al. | Jul 2007 | A1 |
20070238089 | Rosenthal et al. | Oct 2007 | A1 |
20070243523 | Ionescu-Zanetti et al. | Oct 2007 | A1 |
20070252265 | Sander | Nov 2007 | A1 |
20070264675 | Toner et al. | Nov 2007 | A1 |
20070264705 | Dodgson | Nov 2007 | A1 |
20070275418 | Hollmann et al. | Nov 2007 | A1 |
20080003224 | Fong et al. | Jan 2008 | A1 |
20080014589 | Link et al. | Jan 2008 | A1 |
20080068588 | Hess et al. | Mar 2008 | A1 |
20080090239 | Shoemaker et al. | Apr 2008 | A1 |
20080096212 | Bell et al. | Apr 2008 | A1 |
20080113358 | Kapur et al. | May 2008 | A1 |
20080113906 | Ding et al. | May 2008 | A1 |
20080124726 | Monforte | May 2008 | A1 |
20080182273 | Hansen et al. | Jul 2008 | A1 |
20080206751 | Squirrell et al. | Aug 2008 | A1 |
20080207615 | Bell et al. | Aug 2008 | A1 |
20080220422 | Shoemaker et al. | Sep 2008 | A1 |
20080234264 | Bell et al. | Sep 2008 | A1 |
20080240539 | George et al. | Oct 2008 | A1 |
20080257735 | Jeon et al. | Oct 2008 | A1 |
20080317325 | Ortyn et al. | Dec 2008 | A1 |
20090014360 | Toner et al. | Jan 2009 | A1 |
20090061450 | Hunter | Mar 2009 | A1 |
20090081773 | Kaufman | Mar 2009 | A1 |
20090141593 | Taha | Jun 2009 | A1 |
20090153844 | Peter et al. | Jun 2009 | A1 |
20090162853 | Clark et al. | Jun 2009 | A1 |
20090215088 | Forsyth et al. | Aug 2009 | A1 |
20090220979 | Davis et al. | Sep 2009 | A1 |
20090258383 | Kovac et al. | Oct 2009 | A1 |
20090317836 | Kuhn et al. | Dec 2009 | A1 |
20100120077 | Daridon | May 2010 | A1 |
20100127168 | Khursheed | May 2010 | A1 |
20100210009 | Willson et al. | Aug 2010 | A1 |
20100227387 | Safar et al. | Sep 2010 | A1 |
20100232675 | Ortyn et al. | Sep 2010 | A1 |
20100233693 | Kopf-Sill et al. | Sep 2010 | A1 |
20100261179 | Betley et al. | Oct 2010 | A1 |
20100291584 | Tseng et al. | Nov 2010 | A1 |
20100304485 | Karnik et al. | Dec 2010 | A1 |
20100304978 | Robbins et al. | Dec 2010 | A1 |
20110003380 | Miltenyi et al. | Jan 2011 | A1 |
20110005932 | Jovanovich et al. | Jan 2011 | A1 |
20110045994 | Voldman et al. | Feb 2011 | A1 |
20110053151 | Hansen et al. | Mar 2011 | A1 |
20110104718 | Rao et al. | May 2011 | A1 |
20110117634 | Halamish et al. | May 2011 | A1 |
20110143964 | Zhou et al. | Jun 2011 | A1 |
20110227558 | Mannion et al. | Sep 2011 | A1 |
20110236904 | Hauch et al. | Sep 2011 | A1 |
20110280467 | George et al. | Nov 2011 | A1 |
20120021456 | Levine et al. | Jan 2012 | A1 |
20120071355 | Cooney | Mar 2012 | A9 |
20120071643 | Helfer et al. | Mar 2012 | A1 |
20120129190 | Chiu et al. | May 2012 | A1 |
20120156675 | Lueerssen et al. | Jun 2012 | A1 |
20120164679 | Vrouwe et al. | Jun 2012 | A1 |
20120194805 | Ness et al. | Aug 2012 | A1 |
20130116102 | Hansen | May 2013 | A1 |
20130130376 | Serobyan et al. | May 2013 | A1 |
20130171628 | Di et al. | Jul 2013 | A1 |
20130230860 | Park et al. | Sep 2013 | A1 |
20130244906 | Collins | Sep 2013 | A1 |
20130259635 | Maslana et al. | Oct 2013 | A1 |
20140173443 | Hawkins et al. | Jun 2014 | A1 |
20140212881 | Handique et al. | Jul 2014 | A1 |
20140213487 | Freudenthal et al. | Jul 2014 | A1 |
20140272965 | Handique et al. | Sep 2014 | A1 |
20140315237 | Masujima et al. | Oct 2014 | A1 |
20140357511 | Handique et al. | Dec 2014 | A1 |
20140370612 | Bassler et al. | Dec 2014 | A1 |
20150089359 | Brisebois | Mar 2015 | A1 |
20150093306 | Thorne et al. | Apr 2015 | A1 |
20150133319 | Fu et al. | May 2015 | A1 |
20150160135 | Tibbe et al. | Jun 2015 | A1 |
20150160931 | Glazer et al. | Jun 2015 | A1 |
20150204864 | Fan et al. | Jul 2015 | A1 |
20150299784 | Fan et al. | Oct 2015 | A1 |
20150376609 | Hindson et al. | Dec 2015 | A1 |
20160024572 | Shishkin et al. | Jan 2016 | A1 |
20160024761 | Korb | Jan 2016 | A1 |
20160053253 | Salathia et al. | Feb 2016 | A1 |
20160060621 | Agresti et al. | Mar 2016 | A1 |
20160130649 | Xie et al. | May 2016 | A1 |
20160199838 | Handique et al. | Jul 2016 | A1 |
20160209319 | Adalsteinsson et al. | Jul 2016 | A1 |
20160251714 | Conant et al. | Sep 2016 | A1 |
20160289669 | Fan et al. | Oct 2016 | A1 |
20160314242 | Schnall-Levin et al. | Oct 2016 | A1 |
20160367991 | Petersen et al. | Dec 2016 | A1 |
20170044525 | Kaper et al. | Feb 2017 | A1 |
20170307502 | Mason et al. | Oct 2017 | A1 |
20170320038 | Husain et al. | Nov 2017 | A1 |
20170321252 | Hindson et al. | Nov 2017 | A1 |
20170335385 | Hindson et al. | Nov 2017 | A1 |
20170356027 | Hindson et al. | Dec 2017 | A1 |
20180030515 | Regev et al. | Feb 2018 | A1 |
20180037942 | Fu | Feb 2018 | A1 |
20180051321 | Hindson et al. | Feb 2018 | A1 |
20180080075 | Brenner et al. | Mar 2018 | A1 |
20180094298 | Hindson et al. | Apr 2018 | A1 |
20180094312 | Hindson et al. | Apr 2018 | A1 |
20180105808 | Mikkelsen et al. | Apr 2018 | A1 |
20180112266 | Hindson et al. | Apr 2018 | A1 |
20180127744 | Hu et al. | May 2018 | A1 |
20180127823 | Shekhar et al. | May 2018 | A1 |
20180274027 | Hindson et al. | Sep 2018 | A1 |
20180282804 | Hindson et al. | Oct 2018 | A1 |
20190002814 | Masquelier et al. | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
103894248 | Jul 2014 | CN |
103998394 | Aug 2014 | CN |
104789468 | Jul 2015 | CN |
2414548 | Feb 2012 | EP |
2414548 | Oct 2015 | EP |
2006098696 | Apr 2006 | JP |
2008136415 | Jun 2008 | JP |
2003035909 | May 2003 | WO |
2006098696 | Sep 2006 | WO |
2010120818 | Oct 2010 | WO |
2010142954 | Dec 2010 | WO |
2015133337 | Sep 2015 | WO |
2018013723 | Jan 2018 | WO |
2018058073 | Mar 2018 | WO |
Entry |
---|
Australian Examination Report for Application No. 2018323449, dated Feb. 25, 2020. |
European Search Report for application No. 17870743 dated May 26, 2020. |
Guo, P. et al. Microfluidic capture and release of bacteria in a conical nanopore array. Lab Chip. vol. 12, p. 558-561, 2012, published online Nov. 2011. |
International Search Report and Written Opinion for application No. PCT/US20/31502 dated Sep. 16, 2020. |
International Search Report and Written Opinion for application No. PCT/US17/62099 dated Feb. 12, 2018. |
International Search Report and Written Opinion for PCT Application No. PCT/US2018/048353 dated Nov. 5, 2018. |
Lindstrom, Sara (Royal Institute of Technology, Stockholm, Sweden, 2009, pp. 1-80). |
Seale, K. T. et al. “Mirrored pyramidal wells for simultaneous multiple vantage point microscopy” Journal of Microscopy (2008) 232 1-6 (Year: 2008). |
Sugio, Yoshihiro; et al., An agar-based on-chip neural-cell-cultivation system for stepwise control of network pattern generation during cultivation, Dept. of Life Sciences, Graduate School of Arts and Sciences, University of Tokyo, Jun. 24, 2003. |
Supplemental information from Tan et al. PNAS (2007) 104. (Year: 2007). |
Tan, Wei-Heang et al. “A trap-and-release integrated microfluidic system for dynamic microarray applications.” PNAS (2007) 104 1146-1151. (Year: 2007). |
International Preliminary Report on Patentability for OCT Application No. PCT/US17/62099 dated May 31, 2019. |
Number | Date | Country | |
---|---|---|---|
20210270800 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
61902431 | Nov 2013 | US | |
61779090 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15931928 | May 2020 | US |
Child | 17323176 | US | |
Parent | 16589778 | Oct 2019 | US |
Child | 15931928 | US | |
Parent | 15430833 | Feb 2017 | US |
Child | 16589778 | US | |
Parent | 15199245 | Jun 2016 | US |
Child | 15430833 | US | |
Parent | 14208458 | Mar 2014 | US |
Child | 15199245 | US |